Moti Investments LLC Acquires 6.1% Passive Stake in Elicio Therapeutics, Inc. (ELTX)

On July 16, 2026, Moti Investments LLC filed a Schedule 13G disclosing a new ownership stake in Elicio Therapeutics, Inc. (ELTX). As of the event date on July 1, 2026, the reporting person acquired 1,408,892 shares of common stock, representing a 6.1% ownership interest in the company. Moti Investments LLC, an entity organized under the laws of Saint Kitts and Nevis and based in Dubai, United Arab Emirates, reported sole voting and dispositive power over all disclosed shares. This filing was made under Rule 13d-1(c), indicating a passive investment intent. The certification states that the securities were not acquired for the purpose of changing or influencing the control of the issuer. This transaction marks a significant new position for Moti Investments LLC in the Boston-based biotechnology firm, which focuses on developing cancer immunotherapies. The filing was signed by Kalpana H. Jogani in their capacity as Manager.